A peptide derived from the C-terminal region of acetylcholinesterase modulates extracellular concentrations of acetylcholinesterase in the rat substantia nigra

Neuroscience Letters

Volumn 358, Issue 3, 2004, Pages 210-214

  Emmett, Stevan R ^a   Greenfield, Susan A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Acetylcholinesterase; In vitro release; N methyl D aspartate; Substantia nigra

Indexed keywords

ACETYLCHOLINESTERASE; ALANYLGLUTAMYLPHENYLALANYLHISTIDYLARGINYLTRYPTOPHYLSERYLSERYLTYROSYLMETHION YLVALYLHISTIDYLTRYPTOPHYLLYSINE; N METHYL DEXTRO ASPARTIC ACID; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CARBOXY TERMINAL SEQUENCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME RELEASE; EXTRACELLULAR SPACE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CALCIUM SIGNALING; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; EXTRACELLULAR FLUID; MALE; MOLECULAR SEQUENCE DATA; N-METHYLASPARTATE; NEURONS; PARKINSON DISEASE; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; RATS; RATS, WISTAR; SUBSTANTIA NIGRA;

EID: 1642330078     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2003.12.078     Document Type: Article

References (20)

1. Abdel-Hamid K.D., Tymianski M. Mechanisms and effects of intracellular calcium buffering on neuronal survival in organotypic hippocampal cultures exposed to anoxia/aglycemia or to excitotoxins. J. Neurosci. 17:1997;3538-3553.
2. Bon C.L., Greenfield S.A. Bioactivity of a peptide derived from acetylcholinesterase:electrophysiological characterisation in guinea-pig hippocampus. Eur. J. Neurosci. 17:2003;1991-1995.
3. Day T., Greenfield S.A. A non-cholinergic, trophic action of acetylcholinesterase on hippocampal neurones in vitro: molecular mechanisms. Neuroscience. 111:2002;649-656.
4. Dickie B.G.M., Holmes C., Greenfield S.A. Neurotoxic and neurotrophic effects of chronic N-methyl-D-aspartate exposure upon mesencephalic dopaminergic-neurons in organotypic culture. Neuroscience. 72:1996;731-741.
5. Ellman G.L., Courtney K.D., Andre S.V., Featherstone R.M. A new and rapid determination of acetylcholinesterase activity. Biochem. Pharmacol. 7:1961;88-95.
6. Greenfield S.A., Grunewald R.A., Foley P., Shaw S.G. Origin of various enzymes released from the substantia nigra and caudate nucleus effects of 6-hydroxydopamine lesions of the nigro-striatal pathway. J. Comp. Neurol. 214:1983;87-92.
7. Greenfield S.A., Vaux D. Parkinson's disease, Alzheimer's disease and motor neuron disease: identifying a common mechanism. Neuroscience. 113:(3):2002;485-492.
8. Heiland B., Greenfield S.A. Rat locomotion and release of acetylcholinesterase. Pharmacol. Biochem. Behav. 62:2003;81-87.
9. Hertel C., Terzi E., Hauser N., Jakob-Rotne R., Seelig J., Kemp J.A. Inhibition of the electrostatic interaction between beta-amyloid peptide and membranes prevents beta-amyloid-induced toxicity. Proc. Nat. Acad. Sci. USA. 94:1997;9412-9416.
10. Jones S.A., Dickie B.G., Klegeris A., Greenfield S.A. The subthalamo-nigral pathway regulates movement and concomitant acetylcholinesterase release from the substantia nigra. J. Neural Trans. 98:1994;23-37.
11. Kamenetz F., Tomita T., Hsieh H., Seabrook G., Borchelt D., Iwatsubo T., Sisodia S., Malinow R. APP processing and synaptic function. Neuron. 37:2003;925-937.
12. Karpel R., Sternfeld M., Ginzberg D., Guhl E., Graessmann A., Soreq H. Overexpression of alternative human acetylcholinesterase forms modulates process extensions in cultured glioma cells. J. Neurochem. 66:1996;114-123.
13. Lin J.Y., Lipski J. Dopaminergic substantia nigra neurons express functional NMDA receptors in postnatal rats. J. Neurophysiol. 85:2001;1336-1339.
14. Llinas R., Greenfield S.A., Jahnsen H. Electrophysiology of pars compacta cells in the in vitro substantia nigra - a possible mechanism for dendritic release. Brain Res. 294:1984;127-132.
15. Moran M.A., Mufson E.J., Gomez Ramos P. Colocalization of cholinesterases with beta amyloid protein in aged and Alzheimer's brains. Acta Neuropathol. Berl. 85:1993;362-369.
16. Robakis N.K., Anderson J.P., Refolo L.M., Wallace W. Expression of the Alzheimer amyloid precursor in brain tissue and effects of NGF and EGF on its metabolism. Clin. Neuropharm. 14:(Suppl. 1):1991;15-23.
17. Soreq H., Seidman S. Acetylcholinesterase - new roles for an old actor. Nat. Rev. Neurosci. 2:2001;294-302.
18. Taylor S.J., Jones S.A., Haggblad J., Greenfield S.A. 'On-line' measurement of acetylcholinesterase release from the substantia nigra of the freely-moving guinea-pig. Neuroscience. 37:1990;71-76.
19. 2+ channels: a possible involvement of free radicals. J. Neurochem. 68:1997;265-271.
20. Webb C.P., Nedergaard S., Giles K., Greenfield S.A. Involvement of the NMDA receptor in a non-cholinergic action of acetylcholinesterase in guinea pig substantia nigra pars compacta neurons. Eur. J. Neurosci. 8:1996;837-841.